ARCHIVES

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

This article is from The Cancer Letter archive.

Vol. 36 No. 28 | July 23, 2010

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:

February 7, 1997

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

UC Davis Cancer Center Wins NCI Designation

July 19, 2002

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987